Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58

Andre M. Small, David D. Berg, Itamar Raz, Petr Jarolim, Erica L. Goodrich, Filipe A. Moura, Ofri Mosenzon, Avivit Cahn, Deepak L. Bhatt, Jamie P. Dwyer, Lawrence A. Leiter, John P.H. Wilding, Ingrid Gause-Nilsson, Marc S. Sabatine, David A. Morrow, Stephen D. Wiviott

Open source

DOI: 10.1016/j.ahjo.2026.100929
Published: 2026-11
Container: American Heart Journal Plus: Cardiology Research and Practice
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ahjo.2026.100929,
  title = {Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58},
  author = {Andre M. Small and David D. Berg and Itamar Raz and Petr Jarolim and Erica L. Goodrich and Filipe A. Moura and Ofri Mosenzon and Avivit Cahn and Deepak L. Bhatt and Jamie P. Dwyer and Lawrence A. Leiter and John P.H. Wilding and Ingrid Gause-Nilsson and Marc S. Sabatine and David A. Morrow and Stephen D. Wiviott},
  year = {2026},
  journal = {American Heart Journal Plus: Cardiology Research and Practice},
  doi = {10.1016/j.ahjo.2026.100929},
  url = {https://doi.org/10.1016/j.ahjo.2026.100929}
}

RIS

TY  - JOUR
TI  - Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58
AU  - Andre M. Small
AU  - David D. Berg
AU  - Itamar Raz
AU  - Petr Jarolim
AU  - Erica L. Goodrich
AU  - Filipe A. Moura
AU  - Ofri Mosenzon
AU  - Avivit Cahn
AU  - Deepak L. Bhatt
AU  - Jamie P. Dwyer
AU  - Lawrence A. Leiter
AU  - John P.H. Wilding
AU  - Ingrid Gause-Nilsson
AU  - Marc S. Sabatine
AU  - David A. Morrow
AU  - Stephen D. Wiviott
PY  - 2026
JO  - American Heart Journal Plus: Cardiology Research and Practice
DO  - 10.1016/j.ahjo.2026.100929
UR  - https://doi.org/10.1016/j.ahjo.2026.100929
ER  -

APA

Small, A. M., Berg, D. D., Raz, I., Jarolim, P., Goodrich, E. L., Moura, F. A., Mosenzon, O., Cahn, A., Bhatt, D. L., Dwyer, J. P., Leiter, L. A., Wilding, J. P., Gause-Nilsson, I., Sabatine, M. S., Morrow, D. A., & Wiviott, S. D. (2026). Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58. American Heart Journal Plus: Cardiology Research and Practice. https://doi.org/10.1016/j.ahjo.2026.100929

Source records

crossref · retrieved 2026-11-07T13:58:07.064Z